1. Mimickers of novel coronavirus disease 2019 (COVID-19) on chest CT: spectrum of CT and clinical features
   Ali H. Elmokadem et al, 2021, Insights into Imaging CrossRef
2. Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis
   Stephanie G. C. Kroeze et al, 2021, Cancers CrossRef
3. Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review
   Shanshan Chen et al, 2021, Expert Review of Anticancer Therapy CrossRef
4. Therapeutic Options in Neuro-Oncology
   Mariana Afonso et al, 2022, International Journal of Molecular Sciences CrossRef
5. Anticancer therapy and lung injury: molecular mechanisms
   Li Li et al, 2018, Expert Review of Anticancer Therapy CrossRef
6. Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario
   Henrry Diaz et al, 2022, Frontiers in Public Health CrossRef
7. Erlotinib Induced Fatal Interstitial Lung Disease in a Patient with Metastatic Non-Small Cell Lung Cancer: Case Report and Review of Literature
   Ankit Mangla et al, 2016, Rare Tumors CrossRef
8. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
   Jung Min Song et al, 2016, Oncotarget CrossRef
9. Deciphering the scalene association among type‐2 diabetes mellitus, prostate cancer, and chronic myeloid leukemia via enrichment analysis of disease‐gene network
   Qiong Liu et al, 2019, Cancer Medicine CrossRef
10. Looking into the toxicity potential and clinical benefits of tyrosine kinase inhibitors (TKIs)
    Ramak Ajideh et al, 2024, Encyclopedia of Toxicology CrossRef